// App-Quantinova.ai

: First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial

Researchers

Presenter

  • Stefan Andreas

Principal Investigators

  • Laurent Boyer

  • Guy Brusselle

  • Wim Janssens

  • Edward Kerwin

  • Alberto Papi

  • Bonavuth Pek

  • Luis Puente-Maestu

  • Dinesh Saralaya

  • Henrik Watz

  • Tom Ma Wilkinson

  • Daniela Casula

  • Gennaro Di Maro

  • Maria Lattanzi

  • Luca Moraschini

  • Sonia Schoonbroodt

  • Annaelisa Tasciotti

  • Ashwani K Arora

  • François Maltais

Medical Centers

  • Ctr Hospier Regional de Lanaudiere, Saint-Charles-Borromee, QC, Canada

  • Centre de recherche, Institut Universitaire de cardiologie et de pneumologie de Québec, Laval University, Quebec, Canada

  • University of Ferrara and S. Anna University Hospital, Ferrara, Italy

  • Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Deutsches Zentrum für Lungenforschung, Grosshansdorf, Germany

  • Faculty of Medicine and Institute for Life Sciences, University of Southampton; Southampton NIHR Biomedical Research Centre, University Hospital Southampton Foundation NHS Trust; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom

  • Service de Physiologie-Explorations Fonctionnelles, APHP, Hôpital Henri Mondor, IMRB, Université Paris Est Créteil, Paris, France

  • GSK, Siena, Italy

  • Lungenfachklinik Immenhausen and Universitätsmedizin Göttingen, and Deutsches Zentrum für Lungenforschung, Giessen, Germany

  • Respiratory Department, UZ Leuven, BREATHE, KU Leuven, Leuven, Belgium

  • Universidad Complutense de Madrid/ Respiratory Medicine Department at Hospital Universitario Gregorio Marañón, Madrid, Spain

  • GSK, Rixensart, Belgium

  • Rheumatology, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom

  • Hematology, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium

  • Crisor, LLC, c/o Clinical Research Institute, and Altitude Clinical Consulting, Medford, OR, United States of America

Locations

  • United States

  • Canada

  • United Kingdom

  • Germany

  • Italy

  • Belgium

  • France

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • II

Study Id's

  • NCT03281876

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved